156 related articles for article (PubMed ID: 7540609)
1. Osteoporosis-like changes in Walker carcinoma 256-bearing rats, not accompanied with hypercalcemia or parathyroid hormone-related protein production.
Waki Y; Miyamoto K; Kasugai S; Ohya K
Jpn J Cancer Res; 1995 May; 86(5):470-6. PubMed ID: 7540609
[TBL] [Abstract][Full Text] [Related]
2. Postmenopause-like bone loss by mammary carcinoma Walker256/S which secretes luteinizing hormone-releasing hormone.
Waki Y; Miyamoto K; Yamamoto S; Saitoh Y; Kasugai S; Ohya K
Jpn J Pharmacol; 1999 Jun; 80(2):119-25. PubMed ID: 10440530
[TBL] [Abstract][Full Text] [Related]
3. Walker 256/S carcinosarcoma causes osteoporosis-like changes through ectopical secretion of luteinizing hormone-releasing hormone.
Waki Y; Nomura M; Kasugai S; Ohya K; Miyamoto K
Cancer Res; 1999 Mar; 59(6):1219-24. PubMed ID: 10096551
[TBL] [Abstract][Full Text] [Related]
4. Effects of transforming growth factor beta1 on cell growth and parathyroid hormone-related protein in Walker 256 tumor cells.
Benítez-Verguizas J; Loarte D; de Miguel F; Esbrit P
Life Sci; 1999; 65(17):1807-16. PubMed ID: 10576560
[TBL] [Abstract][Full Text] [Related]
5. Characterization of calcium transport in the luminal and the basolateral membrane from kidney cortex of hypercalcemic rats bearing the Walker 256 carcinosarcoma.
de Miguel F; Esbrit P
Bone Miner; 1993 Oct; 23(1):65-76. PubMed ID: 8274881
[TBL] [Abstract][Full Text] [Related]
6. Pamidronate corrects the down-regulation of the renal parathyroid hormone (PTH)/PTH-related peptide (PTHrP) receptor mRNA in rats bearing Walker tumors.
Yaghoobian J; Morieux C; Denne MA; Bouizar Z; Ureña P; de Vernejoul MC
Horm Metab Res; 1998 May; 30(5):249-55. PubMed ID: 9660083
[TBL] [Abstract][Full Text] [Related]
7. Effects of passive immunization against parathyroid hormone-related protein: PTHrP is the responsible factor in mediating hypercalcemia in the Walker carcinosarcoma 256 rat model.
Schilling T; Blind E; Baier R; Sinn HP; Moallem E; Silver J; Ziegler R; Raue F
J Bone Miner Res; 1995 Jan; 10(1):7-16. PubMed ID: 7747633
[TBL] [Abstract][Full Text] [Related]
8. Characterization of parathyroid hormone/parathyroid hormone-related protein receptor and signaling in hypercalcemic Walker 256 tumor cells.
Esbrit P; Benítez-Verguizas J; de Miguel F; Valín A; García-Ocaña A
J Endocrinol; 2000 Jul; 166(1):11-20. PubMed ID: 10856878
[TBL] [Abstract][Full Text] [Related]
9. Glucocorticoids decrease the production of parathyroid hormone-related protein in vitro but not in vivo in the Walker carcinosarcoma 256 rat model.
Schilling T; Pecherstorfer M; Blind E; Kohl B; Wagner H; Ziegler R; Raue F
Bone; 1996 Apr; 18(4):315-9. PubMed ID: 8726387
[TBL] [Abstract][Full Text] [Related]
10. Passive immunization with anti-parathyroid hormone-related protein monoclonal antibody markedly prolongs survival time of hypercalcemic nude mice bearing transplanted human PTHrP-producing tumors.
Sato K; Yamakawa Y; Shizume K; Satoh T; Nohtomi K; Demura H; Akatsu T; Nagata N; Kasahara T; Ohkawa H
J Bone Miner Res; 1993 Jul; 8(7):849-60. PubMed ID: 8352067
[TBL] [Abstract][Full Text] [Related]
11. Inhibition by human interleukin-1 alpha of parathyroid hormone-related peptide effects on renal calcium and phosphorus metabolism in the rat.
Tørring O; Turner RT; Carter WB; Firek AF; Jacobs CA; Heath H
Endocrinology; 1992 Jul; 131(1):5-13. PubMed ID: 1319327
[TBL] [Abstract][Full Text] [Related]
12. 1,25 dihydroxyvitamin D and dexamethasone decrease in vivo Walker carcinoma growth, but not parathyroid hormone related protein secretion.
Cohen-Solal ME; Bouizar Z; Denne MA; Graulet AM; Gueris J; Bracq S; Jullienne A; de Vernejoul MC
Horm Metab Res; 1995 Sep; 27(9):403-7. PubMed ID: 8557238
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of bone resorption results in a selective increase in the growth rate of spontaneously metastatic Walker 256 cancer cells in bone.
Kostenuik PJ; Singh G; Suyama KL; Orr FW
Clin Exp Metastasis; 1992 Nov; 10(6):411-8. PubMed ID: 1451351
[TBL] [Abstract][Full Text] [Related]
14. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
[TBL] [Abstract][Full Text] [Related]
15. Dependence of humoral hypercalcemia of malignancy on parathyroid hormone-related protein expression in the canine anal sac apocrine gland adenocarcinoma (CAC-8) nude mouse model.
Gröne A; Weckmann MT; Blomme EA; Capen CC; Rosol TJ
Vet Pathol; 1998 Sep; 35(5):344-51. PubMed ID: 9754539
[TBL] [Abstract][Full Text] [Related]
16. Effects of different dosages of parathyroid hormone-related protein 1-34 on the bone metabolism of the ovariectomized rat model of osteoporosis.
Xu J; Rong H; Ji H; Wang D; Wang J; Zhang W; Zhang Y
Calcif Tissue Int; 2013 Sep; 93(3):276-87. PubMed ID: 23807531
[TBL] [Abstract][Full Text] [Related]
17. Osteolytic activity of Walker carcinosarcoma 256 is due to parathyroid hormone-related protein (PTHrP).
Scharla SH; Minne HW; Lempert UG; Krieg P; Rappel S; Maurer E; Grohe U; Ziegler R
Horm Metab Res; 1991 Feb; 23(2):66-9. PubMed ID: 1646150
[TBL] [Abstract][Full Text] [Related]
18. Proliferative effect of parathyroid hormone-related protein on the hypercalcemic Walker 256 carcinoma cell line.
Benítez-Verguizas J; Esbrit P
Biochem Biophys Res Commun; 1994 Feb; 198(3):1281-9. PubMed ID: 7509601
[TBL] [Abstract][Full Text] [Related]
19. Calcium supplementation does not reproduce the pharmacological efficacy of alfacalcidol for the treatment of osteoporosis in rats.
Shiraishi A; Ito M; Hayakawa N; Kubota N; Kubodera N; Ogata E
Calcif Tissue Int; 2006 Mar; 78(3):152-61. PubMed ID: 16525749
[TBL] [Abstract][Full Text] [Related]
20. The hypercalcemic Walker carcinosarcoma 256 of the rat causes an increase in serum 1,25-dihydroxyvitamin D3.
Scharla SH; Minne HW; Oswald C; Lempert UG; Schmidt-Gayk H; Ziegler R
Bone Miner; 1989 May; 6(2):155-64. PubMed ID: 2765706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
